WO2000037163A1 - Integrated portable biological detection system - Google Patents
Integrated portable biological detection system Download PDFInfo
- Publication number
- WO2000037163A1 WO2000037163A1 PCT/US1999/031098 US9931098W WO0037163A1 WO 2000037163 A1 WO2000037163 A1 WO 2000037163A1 US 9931098 W US9931098 W US 9931098W WO 0037163 A1 WO0037163 A1 WO 0037163A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- integrated system
- integrated
- sample
- electrodes
- flow cell
- Prior art date
Links
- 238000001514 detection method Methods 0.000 title description 21
- 239000000523 sample Substances 0.000 claims abstract description 96
- 238000000926 separation method Methods 0.000 claims abstract description 37
- 238000009396 hybridization Methods 0.000 claims abstract description 29
- 210000004027 cell Anatomy 0.000 claims description 205
- 238000004458 analytical method Methods 0.000 claims description 58
- 238000006243 chemical reaction Methods 0.000 claims description 57
- 230000003321 amplification Effects 0.000 claims description 52
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 52
- 238000002360 preparation method Methods 0.000 claims description 35
- 238000009739 binding Methods 0.000 claims description 23
- 230000027455 binding Effects 0.000 claims description 22
- 239000011159 matrix material Substances 0.000 claims description 20
- 238000010438 heat treatment Methods 0.000 claims description 16
- 230000009089 cytolysis Effects 0.000 claims description 15
- 108091005804 Peptidases Proteins 0.000 claims description 14
- 239000004365 Protease Substances 0.000 claims description 14
- 238000005286 illumination Methods 0.000 claims description 14
- 239000003446 ligand Substances 0.000 claims description 13
- 239000000758 substrate Substances 0.000 claims description 13
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 11
- 239000012472 biological sample Substances 0.000 claims description 10
- 230000005855 radiation Effects 0.000 claims description 9
- 230000006037 cell lysis Effects 0.000 claims description 8
- 108010067770 Endopeptidase K Proteins 0.000 claims description 7
- 210000000170 cell membrane Anatomy 0.000 claims description 7
- 210000001236 prokaryotic cell Anatomy 0.000 claims description 7
- 230000003993 interaction Effects 0.000 claims description 6
- 238000006911 enzymatic reaction Methods 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims 4
- 238000007900 DNA-DNA hybridization Methods 0.000 claims 3
- 230000009149 molecular binding Effects 0.000 claims 3
- 238000007899 nucleic acid hybridization Methods 0.000 claims 3
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 12
- 238000004720 dielectrophoresis Methods 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 7
- 206010028980 Neoplasm Diseases 0.000 abstract description 4
- 230000001580 bacterial effect Effects 0.000 abstract description 4
- 201000011510 cancer Diseases 0.000 abstract description 3
- 230000004544 DNA amplification Effects 0.000 abstract description 2
- 239000003298 DNA probe Substances 0.000 abstract description 2
- 239000000975 dye Substances 0.000 abstract description 2
- 239000003550 marker Substances 0.000 abstract description 2
- 239000007850 fluorescent dye Substances 0.000 abstract 1
- 238000003384 imaging method Methods 0.000 abstract 1
- 238000001499 laser induced fluorescence spectroscopy Methods 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 description 47
- 108020004707 nucleic acids Proteins 0.000 description 44
- 102000039446 nucleic acids Human genes 0.000 description 44
- 238000000034 method Methods 0.000 description 40
- 239000000463 material Substances 0.000 description 27
- 108090000623 proteins and genes Proteins 0.000 description 25
- 102000004169 proteins and genes Human genes 0.000 description 22
- 239000000872 buffer Substances 0.000 description 17
- 238000012545 processing Methods 0.000 description 16
- 238000002493 microarray Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 12
- 238000011282 treatment Methods 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 10
- 210000000601 blood cell Anatomy 0.000 description 10
- 238000011033 desalting Methods 0.000 description 9
- 108700026220 vif Genes Proteins 0.000 description 9
- 230000008569 process Effects 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 101150064691 Q gene Proteins 0.000 description 7
- 238000003556 assay Methods 0.000 description 7
- 210000003527 eukaryotic cell Anatomy 0.000 description 7
- 238000003752 polymerase chain reaction Methods 0.000 description 7
- 230000000717 retained effect Effects 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- 239000012530 fluid Substances 0.000 description 6
- 230000001413 cellular effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 235000019419 proteases Nutrition 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 101710163270 Nuclease Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 239000012491 analyte Substances 0.000 description 4
- 239000012620 biological material Substances 0.000 description 4
- 208000019065 cervical carcinoma Diseases 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000012510 hollow fiber Substances 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 238000002032 lab-on-a-chip Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- 241000191938 Micrococcus luteus Species 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 241001138501 Salmonella enterica Species 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 230000005684 electric field Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 230000009871 nonspecific binding Effects 0.000 description 3
- 108091033319 polynucleotide Proteins 0.000 description 3
- 102000040430 polynucleotide Human genes 0.000 description 3
- 239000002157 polynucleotide Substances 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 108091093088 Amplicon Proteins 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108091005461 Nucleic proteins Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000000835 electrochemical detection Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000012632 fluorescent imaging Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 230000007023 DNA restriction-modification system Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- RZCIEJXAILMSQK-JXOAFFINSA-N TTP Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 RZCIEJXAILMSQK-JXOAFFINSA-N 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000005465 channeling Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 101150114988 invA gene Proteins 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004976 peripheral blood cell Anatomy 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 101150021607 rppH gene Proteins 0.000 description 1
- 101150082821 sacA gene Proteins 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 101150070603 yadA gene Proteins 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- G01N15/1433—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Electro-optical investigation, e.g. flow cytometers
- G01N15/1484—Electro-optical investigation, e.g. flow cytometers microstructural devices
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU25950/00A AU763514B2 (en) | 1998-12-23 | 1999-12-22 | Integrated portable biological detection system |
JP2000589268A JP2002536962A (en) | 1998-12-23 | 1999-12-22 | Integrated portable biological detection system |
BR9916840-5A BR9916840A (en) | 1998-12-23 | 1999-12-22 | Integrated portable biological detection system |
EP19990968558 EP1144092A4 (en) | 1998-12-23 | 1999-12-22 | Integrated portable biological detection system |
KR1020017007947A KR20010102961A (en) | 1998-12-23 | 1999-12-22 | Integrated Portable Biological Detection System |
CA002353461A CA2353461A1 (en) | 1998-12-23 | 1999-12-22 | Integrated portable biological detection system |
NZ512087A NZ512087A (en) | 1998-12-23 | 1999-12-22 | Integrated portable biological detection system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11373098P | 1998-12-23 | 1998-12-23 | |
US60/113,730 | 1998-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000037163A1 true WO2000037163A1 (en) | 2000-06-29 |
Family
ID=22351155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/031098 WO2000037163A1 (en) | 1998-12-23 | 1999-12-22 | Integrated portable biological detection system |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1144092A4 (en) |
JP (1) | JP2002536962A (en) |
KR (1) | KR20010102961A (en) |
AU (1) | AU763514B2 (en) |
BR (1) | BR9916840A (en) |
CA (1) | CA2353461A1 (en) |
NZ (1) | NZ512087A (en) |
WO (1) | WO2000037163A1 (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1176213A2 (en) * | 2000-07-27 | 2002-01-30 | Becton Dickinson and Company | Amplification and detection of legionella pneumophila nucleic acids |
JP2002214192A (en) * | 2001-01-19 | 2002-07-31 | Seiko Instruments Inc | Gene detection system, gene detecting device and method equipped therewith, and gene detecting chip |
JP2002320488A (en) * | 2000-07-27 | 2002-11-05 | Becton Dickinson & Co | Amplification and detection of mycoplasma pneumoniae |
JP2002320487A (en) * | 2000-07-27 | 2002-11-05 | Becton Dickinson & Co | Amplification and detection of bordetella pertusis |
US6492122B2 (en) | 2000-11-09 | 2002-12-10 | Nanogen, Inc. | Quantitative analysis methods on active electronic microarrays |
KR100393131B1 (en) * | 2001-03-15 | 2003-07-31 | 케이맥(주) | Method for crystalizing proteins in nano scale, and chamber for crystalizing proteins and chip comprising the same |
WO2003080868A1 (en) * | 2002-03-27 | 2003-10-02 | Jae-Chern Yoo | Bio-disc, bio-driver apparatus, and assay method using the same |
JP2004147658A (en) * | 2002-10-31 | 2004-05-27 | Hewlett-Packard Development Co Lp | Microfluidic system for analyzing nucleic acid |
EP1517752A2 (en) * | 2002-05-03 | 2005-03-30 | The Regents Of The University Of California | Fast electrical lysis of cells and rapid collection of the contents thereof using capillary electrophoresis |
US6881314B1 (en) | 2000-09-30 | 2005-04-19 | Aviva Biosciences Corporation | Apparatuses and methods for field flow fractionation of particles using acoustic and other forces |
US6884395B2 (en) | 2000-05-12 | 2005-04-26 | Gyros Ab | Integrated microfluidic disc |
EP1548104A1 (en) * | 2002-08-26 | 2005-06-29 | Japan Science and Technology Agency | Nucleic acid recovery chip and nucleic acid recovery device |
WO2005108571A1 (en) * | 2004-05-07 | 2005-11-17 | Konica Minolta Medical & Graphic, Inc. | Micro-reactor for testing, genetic testing apparatus, and genetic testing method |
US7081192B1 (en) | 2000-08-08 | 2006-07-25 | Aviva Biosciences Corporation | Methods for manipulating moieties in microfluidic systems |
US7357852B2 (en) | 2001-08-24 | 2008-04-15 | Applera Corporation | Bubble-free and pressure-generating electrodes for electrophoretic and electroosmotic devices |
DE102005059536B4 (en) * | 2005-12-13 | 2008-08-28 | Siemens Ag | Method and biochip for studying a biological sample |
CN101544351B (en) * | 2009-05-08 | 2011-12-14 | 东南大学 | Low-dimensional nanophase material high-flexibility assembling chip and application method |
US8585971B2 (en) | 2005-04-05 | 2013-11-19 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
US8895298B2 (en) | 2002-09-27 | 2014-11-25 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
WO2015044191A1 (en) | 2013-09-24 | 2015-04-02 | Ait Austrian Institute Of Technology Gmbh | Method for pathogen isolation |
US9017942B2 (en) | 2006-06-14 | 2015-04-28 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
WO2015103225A1 (en) * | 2013-12-31 | 2015-07-09 | Illumina, Inc. | Addressable flow cell using patterned electrodes |
US9127308B2 (en) | 2002-03-07 | 2015-09-08 | Atlas Genetics Limited | Nucleic acid probes, their synthesis and use |
US20180156788A1 (en) * | 2015-06-30 | 2018-06-07 | Imec Vzw | Sensor Device |
CN109313214A (en) * | 2017-01-05 | 2019-02-05 | 伊鲁米那股份有限公司 | Shared pipeline selector valve for system |
US11378498B2 (en) | 2006-06-14 | 2022-07-05 | Verinata Health, Inc. | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100441893B1 (en) * | 2002-08-03 | 2004-07-27 | 학교법인 포항공과대학교 | Nucleic acid separation device using MEMS component |
ATE449962T1 (en) * | 2003-02-05 | 2009-12-15 | Gen Hospital Corp | MICROCHIP-BASED SYSTEM FOR HIV DIAGNOSTICS |
KR102562371B1 (en) * | 2021-08-19 | 2023-08-02 | (주)엠큐빅 | Microalgae analysis device using artificial intelligence |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4661451A (en) * | 1984-02-06 | 1987-04-28 | Ortho Diagnostic Systems, Inc. | Methods for immobilizing and translocating biological cells |
US5605662A (en) * | 1993-11-01 | 1997-02-25 | Nanogen, Inc. | Active programmable electronic devices for molecular biological analysis and diagnostics |
US5795457A (en) * | 1990-01-30 | 1998-08-18 | British Technology Group Ltd. | Manipulation of solid, semi-solid or liquid materials |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6071394A (en) * | 1996-09-06 | 2000-06-06 | Nanogen, Inc. | Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis |
US5856174A (en) * | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
GB9615775D0 (en) * | 1996-07-26 | 1996-09-04 | British Tech Group | Apparatus and method for characterising particles using dielectrophoresis |
-
1999
- 1999-12-22 NZ NZ512087A patent/NZ512087A/en unknown
- 1999-12-22 EP EP19990968558 patent/EP1144092A4/en not_active Withdrawn
- 1999-12-22 JP JP2000589268A patent/JP2002536962A/en active Pending
- 1999-12-22 BR BR9916840-5A patent/BR9916840A/en not_active IP Right Cessation
- 1999-12-22 KR KR1020017007947A patent/KR20010102961A/en not_active Application Discontinuation
- 1999-12-22 CA CA002353461A patent/CA2353461A1/en not_active Abandoned
- 1999-12-22 AU AU25950/00A patent/AU763514B2/en not_active Ceased
- 1999-12-22 WO PCT/US1999/031098 patent/WO2000037163A1/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4661451A (en) * | 1984-02-06 | 1987-04-28 | Ortho Diagnostic Systems, Inc. | Methods for immobilizing and translocating biological cells |
US5795457A (en) * | 1990-01-30 | 1998-08-18 | British Technology Group Ltd. | Manipulation of solid, semi-solid or liquid materials |
US5605662A (en) * | 1993-11-01 | 1997-02-25 | Nanogen, Inc. | Active programmable electronic devices for molecular biological analysis and diagnostics |
Non-Patent Citations (1)
Title |
---|
See also references of EP1144092A4 * |
Cited By (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7332126B2 (en) | 1999-12-23 | 2008-02-19 | Gyros Patent Ab | Integrated microfluidic disc |
US6884395B2 (en) | 2000-05-12 | 2005-04-26 | Gyros Ab | Integrated microfluidic disc |
EP1176213A2 (en) * | 2000-07-27 | 2002-01-30 | Becton Dickinson and Company | Amplification and detection of legionella pneumophila nucleic acids |
JP2002320488A (en) * | 2000-07-27 | 2002-11-05 | Becton Dickinson & Co | Amplification and detection of mycoplasma pneumoniae |
JP2002320487A (en) * | 2000-07-27 | 2002-11-05 | Becton Dickinson & Co | Amplification and detection of bordetella pertusis |
JP2002320486A (en) * | 2000-07-27 | 2002-11-05 | Becton Dickinson & Co | Amplification and detection of legionella pneumophila |
EP1176213A3 (en) * | 2000-07-27 | 2003-07-30 | Becton Dickinson and Company | Amplification and detection of legionella pneumophila nucleic acids |
US7081192B1 (en) | 2000-08-08 | 2006-07-25 | Aviva Biosciences Corporation | Methods for manipulating moieties in microfluidic systems |
US6881314B1 (en) | 2000-09-30 | 2005-04-19 | Aviva Biosciences Corporation | Apparatuses and methods for field flow fractionation of particles using acoustic and other forces |
US6492122B2 (en) | 2000-11-09 | 2002-12-10 | Nanogen, Inc. | Quantitative analysis methods on active electronic microarrays |
JP4505776B2 (en) * | 2001-01-19 | 2010-07-21 | 凸版印刷株式会社 | Gene detection system, gene detection apparatus equipped with the same, detection method, and gene detection chip |
JP2002214192A (en) * | 2001-01-19 | 2002-07-31 | Seiko Instruments Inc | Gene detection system, gene detecting device and method equipped therewith, and gene detecting chip |
KR100393131B1 (en) * | 2001-03-15 | 2003-07-31 | 케이맥(주) | Method for crystalizing proteins in nano scale, and chamber for crystalizing proteins and chip comprising the same |
US7357852B2 (en) | 2001-08-24 | 2008-04-15 | Applera Corporation | Bubble-free and pressure-generating electrodes for electrophoretic and electroosmotic devices |
US10094800B2 (en) | 2002-03-07 | 2018-10-09 | Atlas Genetics Limited | Assays and apparatus for detecting electrochemical active markers in an electric field |
US9127308B2 (en) | 2002-03-07 | 2015-09-08 | Atlas Genetics Limited | Nucleic acid probes, their synthesis and use |
WO2003080868A1 (en) * | 2002-03-27 | 2003-10-02 | Jae-Chern Yoo | Bio-disc, bio-driver apparatus, and assay method using the same |
EP1517752A2 (en) * | 2002-05-03 | 2005-03-30 | The Regents Of The University Of California | Fast electrical lysis of cells and rapid collection of the contents thereof using capillary electrophoresis |
EP1517752A4 (en) * | 2002-05-03 | 2009-07-08 | Univ California | Fast electrical lysis of cells and rapid collection of the contents thereof using capillary electrophoresis |
EP1548104A1 (en) * | 2002-08-26 | 2005-06-29 | Japan Science and Technology Agency | Nucleic acid recovery chip and nucleic acid recovery device |
EP1548104A4 (en) * | 2002-08-26 | 2008-06-25 | Japan Science & Tech Agency | Nucleic acid recovery chip and nucleic acid recovery device |
US8895298B2 (en) | 2002-09-27 | 2014-11-25 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US8986966B2 (en) | 2002-09-27 | 2015-03-24 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US11052392B2 (en) | 2002-09-27 | 2021-07-06 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US10081014B2 (en) | 2002-09-27 | 2018-09-25 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
JP2004147658A (en) * | 2002-10-31 | 2004-05-27 | Hewlett-Packard Development Co Lp | Microfluidic system for analyzing nucleic acid |
WO2005108571A1 (en) * | 2004-05-07 | 2005-11-17 | Konica Minolta Medical & Graphic, Inc. | Micro-reactor for testing, genetic testing apparatus, and genetic testing method |
US9956562B2 (en) | 2005-04-05 | 2018-05-01 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
US8585971B2 (en) | 2005-04-05 | 2013-11-19 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
US10786817B2 (en) | 2005-04-05 | 2020-09-29 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
US9174222B2 (en) | 2005-04-05 | 2015-11-03 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
DE102005059536B4 (en) * | 2005-12-13 | 2008-08-28 | Siemens Ag | Method and biochip for studying a biological sample |
US9005951B2 (en) | 2005-12-13 | 2015-04-14 | Boehringer Ingelheim Vetmedica Gmbh | Method and biochip for studying a chemical sample |
US9347100B2 (en) | 2006-06-14 | 2016-05-24 | Gpb Scientific, Llc | Rare cell analysis using sample splitting and DNA tags |
US11781187B2 (en) | 2006-06-14 | 2023-10-10 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US9273355B2 (en) | 2006-06-14 | 2016-03-01 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US10155984B2 (en) | 2006-06-14 | 2018-12-18 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US11378498B2 (en) | 2006-06-14 | 2022-07-05 | Verinata Health, Inc. | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
US9017942B2 (en) | 2006-06-14 | 2015-04-28 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
CN101544351B (en) * | 2009-05-08 | 2011-12-14 | 东南大学 | Low-dimensional nanophase material high-flexibility assembling chip and application method |
US10954546B2 (en) | 2013-09-24 | 2021-03-23 | Ait Austrian Institute Of Technology Gmbh | Method for pathogen isolation |
WO2015044191A1 (en) | 2013-09-24 | 2015-04-02 | Ait Austrian Institute Of Technology Gmbh | Method for pathogen isolation |
WO2015103225A1 (en) * | 2013-12-31 | 2015-07-09 | Illumina, Inc. | Addressable flow cell using patterned electrodes |
US10537889B2 (en) | 2013-12-31 | 2020-01-21 | Illumina, Inc. | Addressable flow cell using patterned electrodes |
AU2016287460B2 (en) * | 2015-06-30 | 2021-06-24 | Imec Vzw | Sensor device |
US20180156788A1 (en) * | 2015-06-30 | 2018-06-07 | Imec Vzw | Sensor Device |
US10865442B2 (en) | 2017-01-05 | 2020-12-15 | Illumina, Inc. | Common line selector valve for a system |
CN109313214A (en) * | 2017-01-05 | 2019-02-05 | 伊鲁米那股份有限公司 | Shared pipeline selector valve for system |
Also Published As
Publication number | Publication date |
---|---|
JP2002536962A (en) | 2002-11-05 |
EP1144092A1 (en) | 2001-10-17 |
CA2353461A1 (en) | 2000-06-29 |
NZ512087A (en) | 2003-05-30 |
KR20010102961A (en) | 2001-11-17 |
AU2595000A (en) | 2000-07-12 |
AU763514B2 (en) | 2003-07-24 |
BR9916840A (en) | 2001-10-09 |
EP1144092A4 (en) | 2002-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6403367B1 (en) | Integrated portable biological detection system | |
AU763514B2 (en) | Integrated portable biological detection system | |
US7857957B2 (en) | Integrated portable biological detection system | |
JP7318975B2 (en) | Nucleic acid sample preparation | |
US6638482B1 (en) | Reconfigurable detection and analysis apparatus and method | |
US6309602B1 (en) | Stacked, reconfigurable system for electrophoretic transport of charged materials | |
US6319472B1 (en) | System including functionally separated regions in electrophoretic system | |
AU743074B2 (en) | Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis | |
US6375899B1 (en) | Electrophoretic buss for transport of charged materials in a multi-chamber system | |
JP3558294B2 (en) | Polynucleotide amplification analysis using microfabrication equipment | |
US20040077074A1 (en) | Multi-chambered analysis device | |
US6129828A (en) | Apparatus and methods for active biological sample preparation | |
US6376181B2 (en) | Method for analyzing nucleic acids by means of a substrate having a microchannel structure containing immobilized nucleic acid probes | |
JP4213161B2 (en) | Microfluidic device having thin film electronic device | |
MXPA05004606A (en) | Microfluidic system for analysis of nucleic acids. | |
MXPA05004470A (en) | Microfluidic system utilizing thin-film layers to route fluid. | |
KR20110008174A (en) | Microfluidic chip devices and their use | |
WO2003011768A2 (en) | Microfluidic device for molecular analysis | |
WO2000032744A9 (en) | Apparatus and methods for transport of charged biological materials | |
Cheng et al. | Fluorescent imaging of cells and nucleic acids in bioelectronic chips | |
US20100056388A1 (en) | Nucleic acid array having fixed nucleic acid anti-probes and complementary free nucleic acid probes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 512087 Country of ref document: NZ |
|
ENP | Entry into the national phase |
Ref document number: 2353461 Country of ref document: CA Ref country code: CA Ref document number: 2353461 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999968558 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 25950/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017007947 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 589268 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1999968558 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017007947 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 25950/00 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999968558 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1020017007947 Country of ref document: KR |